The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

Among these approaches is CRISPR, a gene editing technology used to make precise changes to the DNA of plants and animals. Morocco World News spoke with Valentine Otang Ntui, an associate ...

Beyoncé wins album of the year Grammy for ‘Cowboy Carter’ Cruciferous vegetables are the secret to a healthy diet — here are 9 you should be eating Luka Doncic snubs Mavericks in farewell ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...

Pluristyx makes and sells PluriBank™ iPSC lines as part of their tools, technologies, and services to support the development of cellular therapies, and is currently performing gene editing of ...

This gene-editing tool has been adapted for molecular diagnostics, utilizing Cas proteins ... diagnosis. 9 In addition to its application in infectious diseases, there are several CRISPR-based ...

These unique, branched molecules help LNPs break through the endosomal membrane, making them more effective at delivering mRNA and gene-editing tools. In a recent study in Nature Communications ...

Zhi-Kun Li at the Chinese Academy of Sciences in Beijing and his colleagues used CRISPR to create the mice ... The team used gene editing to knock out imprinted genes altogether.

Though GNN has reported that several sickle cell disease patients have already been successfully treated with CRISPR gene editing technology, a new method of addressing this debilitating condition ...

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%.